Clinical Trial Update: A Phase II Study of AS1411 in Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase II clinical trial of AS1411 for metastatic renal cell carcinoma is noted, with the study status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• AS1411

Snippet

Sponsor: Antisoma Research | Conditions: Metastatic Renal Cell Carcinoma | Phase 2 | Status: UNKNOWN